Buy Amaryl Online

Amaryl is an anti-diabetic drug, used to control high blood sugar.

Amaryl 1mg
30 pills x 1mg	$12.87	only $0.43 per pill	Buy Amaryl
60 pills x 1mg	$24.6	only $0.41 per pill	Buy Amaryl
90 pills x 1mg	$35.1	only $0.39 per pill	Buy Amaryl
Amaryl 2mg
30 pills x 2mg	$23.96	only $0.8 per pill	Buy Amaryl
60 pills x 2mg	$46.8	only $0.78 per pill	Buy Amaryl
90 pills x 2mg	$66.5	only $0.74 per pill	Buy Amaryl
Amaryl 4mg
30 pills x 4mg	$43.56	only $1.45 per pill	Buy Amaryl
60 pills x 4mg	$84	only $1.4 per pill	Buy Amaryl
90 pills x 4mg	$121.5	only $1.35 per pill	Buy Amaryl

INDICATIONS

AMARYL is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin-dependent (Type 2) diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled by diet and exercise alone. AMARYL may be used concomitantly with metformin when diet, exercise, and AMARYL or metformin alone do not result in adequate glycemic control.

AMARYL is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycemic agent. Combined use of glimepiride and insulin may increase the potential for hypoglycemia.

In initiating treatment for noninsulin-dependent diabetes, diet and exercise should be emphasized as the primary form of treatment. Caloric restriction, weight loss, and exercise are essential in the obese diabetic patient. Proper dietary management and exercise alone may be effective in controlling the blood glucose and symptoms of hyperglycemia. In addition to regular physical activity, cardiovascular risk factors should be identified and corrective measures taken where possible.

If this program of treatment almost reduces symptoms and/or glucose of blood, use of sulfonylurea oral or insulin should be considered. The use of AMARYL must be view (considered) both by the doctor and by the patient to be a treatment besides regime and of financial year and not as a product of substitution for regime and financial year or to be a proper mechanism to avoid food restriction. Besides, the loss of control of glucose of blood of regime and the only financial year can be transitional, by demanding the administration so only short term of AMARYL.

During maintenance programs, AMARYL monotherapy should be discontinued if satisfactory lowering of blood glucose is no longer achieved. Judgments should be based on regular clinical and laboratory evaluations. Secondary failures to AMARYL monotherapy can be treated with AMARYL-insulin combination therapy.

In considering the use of AMARYL in asymptomatic patients, it should be recognized that blood glucose control in Type 2 diabetes has not definitely been established to be effective in preventing the long-term cardiovascular and neural complications of diabetes. However, the Diabetes Control and Complications Trial (DCCT) demonstrated that control of HbA1c and glucose was associated with a decrease in retinopathy, neuropathy, and nephropathy for insulin-dependent diabetic (IDDM) patients.